The Role of Growth Hormone-Releasing Hormone and the Hypothalamic–Pituitary–Somatotropic Axis in Aging: Potential Therapeutic Applications and Risks
Hormone and Metabolic Research · 01.11.2025 · 57 (11) · 662-667
DOI: 10.1055/a-2641-1207 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Hormone and Metabolic Research, erschienen am 01.11.2025. Verfasst von Ioannis Oikonomakos und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany. Hauptthemen laut MEDLINE: Growth Hormone-Releasing Hormone, Aging, Hypothalamo-Hypophyseal System. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 77 Literaturangaben. Gefördert von: Deutsche Forschungsgemeinschaft.
Abstract (Originalsprache)
Aging is marked by a gradual decline in multiple physiological functions, increasing the risk of age-related disorders. Multiple factors have been identified as contributors to aging, many of which are regulated by the hypothalamus. Growth hormone-releasing hormone (GHRH) produced in the hypothalamus is a key regulator of growth hormone (GH) secretion. With aging, both GHRH and GH levels decline, leading to muscle loss, increased fat accumulation, metabolic dysregulation, and cognitive impairments. GH replacement therapy has been explored as a potential intervention to counteract these effects; however, its long-term use is associated with significant risks, including metabolic disturbances, cardiovascular complications, and potential cancer promotion. In contrast, studies suggest that GHRH-based therapies can improve body composition, muscle strength, cognitive function, and cardiovascular health while avoiding the risks linked to direct GH administration. Additionally, preclinical findings indicate that GHRH agonists may offer cardioprotective and immunomodulatory benefits. In this review, we summarize current knowledge on the roles of GHRH and GH in aging, highlight the limitations of GH-based therapies, and discuss the potential of GHRH-based approaches in mitigating age-related decline and improving health span.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Medicine III, University Hospital Carl Gustav Carus, Technische Universität Dresden, Dresden, Germany.
- Ageing Research at King's (ARK), King's College London Faculty of Life Sciences and Medicine, London, United Kingdom of Great Britain and Northern Ireland.
- Department of Physiology, Anatomy and Genetics, Medical Sciences Division, University of Oxford, Oxford, United Kingdom of Great Britain and Northern Ireland.
- School of Cardiovascular and Metabolic Medicine and Sciences, Faculty of Life Sciences & Medicine, King's College London, London, United Kingdom of Great Britain and Northern Ireland.
ORCID-Profile: Charlotte Steenblock
Förderung
- Deutsche Forschungsgemeinschaft
Zitieren
APA
Oikonomakos, I., Siow, R., Bornstein, S. R., & Steenblock, C. (2025). The Role of Growth Hormone-Releasing Hormone and the Hypothalamic–Pituitary–Somatotropic Axis in Aging: Potential Therapeutic Applications and Risks. Hormone and Metabolic Research, 57(11), 662-667. https://doi.org/10.1055/a-2641-1207
Vancouver
Oikonomakos I, Siow R, Bornstein SR, Steenblock C. The Role of Growth Hormone-Releasing Hormone and the Hypothalamic–Pituitary–Somatotropic Axis in Aging: Potential Therapeutic Applications and Risks. Hormone and Metabolic Research. 2025;57(11):662-667. doi:10.1055/a-2641-1207
BibTeX
@article{Oikonomakos2025,
author = {Oikonomakos, Ioannis and Siow, Richard and Bornstein, Stefan R and Steenblock, Charlotte},
title = {The Role of Growth Hormone-Releasing Hormone and the Hypothalamic–Pituitary–Somatotropic Axis in Aging: Potential Therapeutic Applications and Risks},
journal = {Hormone and Metabolic Research},
year = {2025},
volume = {57},
number = {11},
pages = {662--667},
doi = {10.1055/a-2641-1207}
}
EUVIMED